Ceska Gynekol. 2024;89(1):5-10. doi: 10.48095/cccg20245.
The aim of this study was to determine how often changes the stage of the tumour in definitive histology against preoperative clinical stage in patient cohort with diagnosed endometrial cancer.
We evaluated prospectively a cohort of 166 patients with endometrial cancer. They all underwent abdominal hysterectomy, bilateral salpingo-oophorectomy, sentinel lymph node biopsy. Patients with high-risk tumours also pelvic lymfadenectomy. We collected data of preoperative diagnostic biopsy and postoperative definitive histology. The data were statistically processed.
Detection of sentinel lymph node was successful in 71.1%, bilateral successful detection was in 40.6%. Discrepancy of tumour grade between preoperative biopsy and definitive histology was generally 31.4%. Upgrading of the tumour was in 22 (14.4%) cases, downgrading in 26 (17%) cases. Upgrade from low-risk to high-risk group of tumours was noticed in eight cases. Histopathological tumour type changed in 6.6%, 4.6% moved to histopathologic high-risk group. The tumour stage changed in definite histology in 57.3%, in 19.2% of cases moved from stage low/intermediate-risk group to intermediate-high/high-risk disease group.
Correct assessment of preoperative clinical stage and histological grade of endometrial cancer is burdened with a high inaccuracy rate. A lot of cases is up-staged after surgical staging and moved to intermediate-high/high-risk disease group. Results confirm the importance of oncogynaecologic centre II. evaluation of histopathology findings from diagnostic biopsies made in referring hospitals. Sentinel lymph node biopsy should be performed even in clinically low/intermediate-risk disease group.
本研究旨在确定在确诊为子宫内膜癌的患者队列中,术前临床分期与术后明确组织学分期相比,肿瘤分期改变的频率。
我们前瞻性评估了 166 例子宫内膜癌患者的队列。所有患者均接受了腹式子宫切除术、双侧输卵管卵巢切除术、前哨淋巴结活检。高危肿瘤患者还进行了盆腔淋巴结切除术。我们收集了术前诊断性活检和术后明确组织学的资料。对数据进行了统计学处理。
成功检测到前哨淋巴结的比例为 71.1%,双侧成功检测到前哨淋巴结的比例为 40.6%。术前活检与明确组织学之间肿瘤分级的差异一般为 31.4%。22 例(14.4%)肿瘤升级,26 例(17%)肿瘤降级。8 例肿瘤从低危组升级为高危组。病理类型改变的有 6.6%,4.6%转移到高危组。明确组织学中肿瘤分期改变的有 57.3%,19.2%的病例从低/中危组转移到中高危/高危疾病组。
正确评估术前临床分期和子宫内膜癌的组织学分级存在很高的不准确性。许多病例在手术分期后分期升高,转移到中高危/高危疾病组。结果证实了肿瘤妇科中心 II 级评估的重要性。应在参考医院对诊断性活检的组织病理学发现进行评估。即使在临床低/中危疾病组,也应进行前哨淋巴结活检。